|
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 6.00 | ACUITE D | Reaffirmed | Issuer not co-operating* | - |
Total Outstanding | 6.00 | - | - |
Total Withdrawn | 0.00 | - | - |
* The issuer did not co-operate; based on best available information. |
Rating Rationale |
Acuité has reaffirmed the long-term rating of ‘ACUITE D’ (read as ACUITE D) on the Rs. 6.00 crore bank facilities of Ayurwin Pharma Private Limited (APPL). The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information. |
About the Company |
Ayurwin Pharma Private Limited (APPL) was established as a proprietorship firm in 2008. Later in 2011, it was converted into a private limited company. The company was promoted by Mr. Shivakumar P.B., who has over a decade of experience in pharmaceutical industry. The company is engaged in developing, manufacturing, selling, and distributing of pharmaceutical products. The manufacturing unit is located in Bangalore (Karnataka). |
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower: |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. |
Limitation regarding information availability: |
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavored to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit rating is based. |
Rating Sensitivity |
"No information provided by the issuer / available for Acuite to comment upon." |
Liquidity Position |
"No information provided by the issuer / available for Acuite to comment upon." |
Outlook |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 17 (Provisional) | FY 16 (Actual) |
Operating Income | Rs. Cr. | 44.02 | 91.90 |
PAT | Rs. Cr. | (9.45) | (3.24) |
PAT Margin | (%) | (21.46) | (3.52) |
Total Debt/Tangible Net Worth | Times | (1.55) | 50.60 |
PBDIT/Interest | Times | (5.67) | (2.89) |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
||||||||||||||||||
|
||||||||||||||||||
* The issuer did not co-operate; based on best available information. |
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |